Partial splenectomy before a hematopoietic stem cell transplantation in children

Jennifer G Hall1, Joanne Kurtzberg, Paul Szabolcs

  • 1Division of Pediatric Surgery, Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA.

Insights

Partial splenectomy before hematopoietic stem cell transplantation (HSCT) in children with hypersplenism safely improves engraftment times. This approach may reduce sepsis risk by preserving spleen function.

Area of Science:

  • Pediatric Hematology
  • Transplant Surgery
  • Immunology

Background:

  • Hypersplenism can delay hematopoietic stem cell (HSC) engraftment in children.
  • Total splenectomy improves engraftment but carries a risk of postsplenectomy sepsis.
  • Partial splenectomy is explored as a safer alternative for spleen preservation.

Purpose of the Study:

  • To evaluate the safety and efficacy of partial splenectomy before HSC transplantation in children with hypersplenism.
  • To compare engraftment rates and complications with nonsplenectomized and total splenectomized patients.

Main Methods:

  • A retrospective study of five children undergoing partial splenectomy before HSC transplantation.
  • Comparison of neutrophil and platelet engraftment rates, graft-versus-host disease, and infection rates.
  • Outcomes analyzed against age-matched controls and total splenectomy cases using Wilcoxon's rank sum test.

Main Results:

  • Partial splenectomy was associated with faster neutrophil and platelet engraftment compared to nonsplenectomized children.
  • Engraftment rates after partial splenectomy were comparable to total splenectomy.
  • No perioperative complications were observed; mean splenic regrowth was 39%.

Conclusions:

  • Partial splenectomy is a safe procedure prior to HSC transplantation in children with hypersplenism.
  • It effectively improves HSC engraftment rates, similar to total splenectomy.
  • Partial splenectomy offers spleen salvage, potentially mitigating the risk of postsplenectomy sepsis.
Abstract

Related Concept Videos

Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...